| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832583A1 Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832582A1 Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these |
| 09/12/2007 | EP1832577A1 Improved prodrugs of CC-1065 analogs |
| 09/12/2007 | EP1832293A1 Remedy for cancer metastasis and cancer metastasis inhibitor |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1831693A2 Use of pta peptides for stratification of individuals having cancer |
| 09/12/2007 | EP1831225A2 Anti-inflammatory pyrazolopyrimidines |
| 09/12/2007 | EP1831216A2 Heteroaromatic derivatives useful as anticancer agents |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831200A2 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 09/12/2007 | EP1831199A1 Novel compounds |
| 09/12/2007 | EP1831198A1 Pyridine carboxamide derivatives for use as anticancer agents |
| 09/12/2007 | EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1831164A1 Heterocyclic compounds as ccr2b antagonists |
| 09/12/2007 | EP1830879A2 Mri guided photodynamic therapy for cancer |
| 09/12/2007 | EP1830876A2 Treatment for cutaneous metastases |
| 09/12/2007 | EP1830868A1 Dap-10 and uses thereof |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830848A1 Use of thiazolidinone derivatives as antiangiogenic agents |
| 09/12/2007 | EP1830847A1 Treatment for cancer |
| 09/12/2007 | EP1830845A2 Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level |
| 09/12/2007 | EP1830838A1 Compositions and methods for treating neoplastic diseases |
| 09/12/2007 | EP1830831A2 Pharmaceutical formulations of gallium salts |
| 09/12/2007 | EP1830827A2 Perfluorocarbon liquids as carcinogen |
| 09/12/2007 | EP1575591A4 Heterocycles and uses thereof |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1395255A4 Cddo-compounds and combination therapies thereof |
| 09/12/2007 | EP1368038B1 Medicament for the administration of amifostine and related compounds |
| 09/12/2007 | EP1351694B1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1257632B1 Simultaneous stimulation and concentration of cells |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP1154788B9 Method for indentifying compounds that modulate sister chromatid separation |
| 09/12/2007 | EP0993613B1 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 09/12/2007 | EP0776161B2 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 09/12/2007 | CN101035906A Telomelysin-GFP gene-containing recombinant virus |
| 09/12/2007 | CN101035810A Modulators of hepatocyte growth factor activator |
| 09/12/2007 | CN101035809A Humanized anti-tag-72 monoclonal antibodies |
| 09/12/2007 | CN101035808A Humanized anti-CMET antagonists |
| 09/12/2007 | CN101035802A Inhibitors of IAP |
| 09/12/2007 | CN101035795A Thiazolyl-dihydro indazoles |
| 09/12/2007 | CN101035769A Pyrimidine urea derivatives as kinase inhibitors |
| 09/12/2007 | CN101035765A 磺酰胺衍生物 Sulfonamide derivatives |
| 09/12/2007 | CN101035564A Humanized anti-5T4 antibodies and anti-5T4 antibody/calicheamicin conjugates |
| 09/12/2007 | CN101035535A Use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 09/12/2007 | CN101035520A CRP lowering agent |
| 09/12/2007 | CN101033253A Recombination Japanese lamprey oral gland Grimin protein induction cell apoptosis and its antineoplastic action |
| 09/12/2007 | CN101033242A Antenna system for a level measurement apparatus |
| 09/12/2007 | CN101033230A Cmptothecine derivative and application thereof |
| 09/12/2007 | CN101033227A Pemetrexed ethylenediamine salt and preparation method thereof |
| 09/12/2007 | CN101033226A 1-furylmethyl-3-substituted indolin-2-one derivative |
| 09/12/2007 | CN101033224A Novel pyrimidines small molecular compound, its preparation method and use |
| 09/12/2007 | CN101033211A 5-chloro-4-hydroxy-2(1H)-pyridone and its preparation method and applicaiton |
| 09/12/2007 | CN101032623A Targeting chitosan carrier guided by folic acid receptor and the preparing method and the application |
| 09/12/2007 | CN101032622A Application of transspecific factors of alpha-fetoprotein in the producing of medicine of inducing masculine liver cancer cells of alpha-fetoprotein into death |
| 09/12/2007 | CN101032612A Medicine preparation for curing inflammation and tumour and its prepn process |
| 09/12/2007 | CN101032548A Chinese traditional medicine combination for curing and preventing prostate cancer or preventing prostate phyma |
| 09/12/2007 | CN101032532A Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof |
| 09/12/2007 | CN101032526A Extractive of east asia scorpion and medicine for preventing and / or curing oral epithelial carcinoma thereof |
| 09/12/2007 | CN101032525A Extracting active principles having extracorporeal anti-tumor function from housefly larva |
| 09/12/2007 | CN101032508A Purpose of miRNA-145 |
| 09/12/2007 | CN101032504A Application of liquiritin in medicines |
| 09/12/2007 | CN101032483A Composing of hydantoin ramification for adjusting estrogen receptor activity and application thereof |
| 09/12/2007 | CN101032481A Application of traditional Chinese medicine justicia lignanoids part as antineoplastic medicine |
| 09/12/2007 | CN101032478A Application of triptolide in the preparing of anti-alimentary tract tumor medicine |
| 09/12/2007 | CN101032475A Medical combination of Carmustine, the preparing method and use thereof |
| 09/12/2007 | CN101032463A Sirolimus injection and preparing technique thereof |
| 09/12/2007 | CN100336797C Tetra substituted chalcone derivative and preparing method and use |
| 09/12/2007 | CN100336555C Danshen capsule for antitumour and its preparation technology |
| 09/12/2007 | CN100336543C Traditional Chinese medicine for treating tumour and its preparation method |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/11/2007 | US7268240 Flavanoid dimers or trimers, formed by oligomerization, then etherifying, esterifying or glycosylating to obtain drugs used as anticarcinogenic agents |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/11/2007 | US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268162 Aloe-emodin derivatives and their use in the treatment of neoplasias |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268136 Compositions useful as inhibitors of protein kinases |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268126 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267825 Suitable for gene therapy |
| 09/11/2007 | US7267821 Antitumor agents; leukemia; |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |